Search Results - "Gardeazabal Gonzalez, I."

3O VHIO immune gene-expression signature (VIGex) to enrich patient selection in immunotherapy phase I clinical trials by Hernando, A., Mancuso, F.M., Braña, I., Saavedra, O., Vieito Villar, M., Gardeazabal Gonzalez, I., Alonso Casal, G., Galvao, V., Azaro Pedrazzoli, A.B., Matos Garcia, I., Berche, R., Wornham, N.A., Saura Manich, C., Argiles Martinez, G., Élez, E., Munoz Couselo, E., Felip, E., Tabernero, J., Vivancos, A., Garralda, E.

Get full text

Early changes in plasma cell-free DNA (cfDNA) as a predictive biomarker of immune checkpoint inhibitors (ICIs) efficacy by Garcia, I. Matos, Moreno, A., Arenillas, C., Carbo, C. Hierro, Munoz-Cosuelo, E., Martin-Liberal, J., Braña, I., Villar, M. Vieito, Azaro, A., Gadea, O. Saavedra Santa, Gonzalez, I. Gardeazabal, Javier, R., Roger, B., Elez, E., Felip, E., Dienstmann, R., Gros, A., Tabernero, J., Toledo, R.D.A., Garralda, E.

Get full text